Cassava Sciences Competitors and Similar CompaniesClear all
Cassava Sciences's competitors and similar companies include Biogen, Anavex, Caraway Therapeutics, Trevi Therapeutics and Imara.
 Cassava Sciences Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. |  Caraway Therapeutics Caraway Therapeutics is a company that discovers drugs for neurodegenerative diseases. |  Imara Imara is a company, dedicated to developing novel therapeutics for people living with sickle cell disease and other hemoglobinopathies. | ||
Founding Date | Founding Date 1998 | Founding Date 1978 | Founding Date 2006 | Founding Date 2018 | Founding Date 2011 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||||
Locations | Locations Austin, US HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations New York, US HQ Reno, US | Locations Cambridge, US HQ | Locations New Haven, US HQ | Locations Boston, US HQ |
Employees | Employees 303% increase | Employees 7,605 | Employees 1623% increase | Employees 4 | Employees 1912% increase | Employees 20 |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) 26.7 b | Valuation ($) 484.6 m | Valuation ($) N/A | Valuation ($) 223.6 m | Valuation ($) 166.1 m |
Financial | ||||||
Net income | Net income ($91m) (FY, 2025) | Net income $1.3b (FY, 2025) | Net income ($46.4m) (FY, 2025) | Net income N/A | Net income ($42.7m) (FY, 2025) | Net income ($103.7m) (FY, 2025) |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12.6m | Total funding raised N/A | Total funding raised $ 94.1m | Total funding raised $ 94m |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyAnavex
HQ
New York, US
Employees
16↑ 23% increase
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View companyCaraway Therapeutics
HQ
Cambridge, US
Caraway Therapeutics is a company that discovers drugs for neurodegenerative diseases.
View company
Trevi Therapeutics
HQ
New Haven, US
Employees
19↑ 12% increase
Trevi Therapeutics is a drug development company.
View company